Associations between Aβ deposition and neurometabolic alterations in Alzheimer's disease: Insights from hybrid 3D MRSI‐PET imaging
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: Understanding the neurometabolic changes associated with amyloid‐β (Aβ) deposition is important for early Alzheimer's disease (AD) diagnosis, but their spatial relationships remained unexplored due to technical limitations. METHODS: We investigated the relationship between Aβ deposition and neuronal and glial metabolites using high‐resolution 3D magnetic resonance spectroscopic imaging (MRSI) (8‐min scan, 2 × 3 × 3 mm 3 resolution) and Aβ‐positron emission tomography (Aβ‐PET) imaging. N‐acetylaspartate, myo‐inositol, and creatine maps were obtained from 174 participants: 39 controls, 65 mild cognitive impairment (MCI), and 70 AD patients. RESULTS: N‐Acetylaspartate levels were negatively correlated with Aβ, while myo‐inositol levels were positively correlated globally. Regional associations with Aβ include N‐acetylaspartate reductions in frontal cortex, anterior cingulate cortex, and precuneus, and myo‐inositol increases in precuneus, lateral temporal, and lateral parietal cortices. Combined MRSI and PET biomarkers achieved the highest diagnostic accuracy for MCI and AD . DISCUSSION: Hybrid high‐resolution 3D MRSI and Aβ‐PET imaging provides valuable insights into Aβ’s impact on neurometabolic changes, improving early AD diagnosis. Highlights: Hybrid 3D magnetic resonance spectroscopic imaging–positron emission tomography (MRSI‐PET) imaging reveals Aβ deposition impact on neurometabolism in Alzheimer's disease (AD). N‐acetylaspartate (NAA) as a neuronal metabolic marker is negatively associated with Aβ globally and locally. Myo‐inositol (mI) as a glial metabolic marker is positively associated with Aβ globally and locally. Combining 3D magnetic resonance spectroscopic imaging (MRSI) and PET biomarkers improves diagnostic accuracy for mild cognitive impairment (MCI) and AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Spatial resolution is limited to ~3-5 mm, which is insufficient for detailed anatomical localization 13,14.”
From Molecular design of MRI probes for targeting amyloid-β species: from in vitro binding to in vivo imaging (2026) · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Haeberlein, S. B., Holtzman, D. M., Jagust, W., Jessen, F., Karlawish, J., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.018 · Cited by 10,537
Tau-targeting therapies for Alzheimer disease
Congdon, E. E., & Sigurdsson, E. M. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0013-z · Cited by 1,113
Tau and Aβ imaging, CSF measures, and cognition in Alzheimer’s disease
Brier, M. R., Gordon, B., Friedrichsen, K., McCarthy, J., Stern, A., Christensen, J., Owen, C., Aldea, P., Su, Y., Hassenstab, J., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf2362 · Cited by 734
Wong, D. F., Rosenberg, P. B., Zhou, Y., Kumar, A., Raymont, V., Ravert, H. T., Dannals, R. F., Nandi, A., Brašić, J. R., Ye, W., et al. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.069088 · Cited by 684
Olmos-Alonso, A., Schetters, S. T. T., Sri, S., Askew, K., Mancuso, R., Vargas-Caballero, M., Holscher, C., Perry, V. H., & Gomez-Nicola, D. (2016) · Brain · doi:10.1093/brain/awv379 · Cited by 532
La Joie, R., Perrotin, A., Barré, L., Hommet, C., Mézenge, F., Ibazizene, M., Camus, V., Abbas, A., Landeau, B., Guilloteau, D., et al. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.2170-12.2012 · Cited by 374
Li, Y., Rinne, J. O., Mosconi, L., Pirraglia, E., Rusinek, H., DeSanti, S., Kemppainen, N., Någren, K., Kim, B.-C., Tsui, W., et al. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-008-0833-y · Cited by 278
Self-citationValidation of amyloid PET positivity thresholds in centiloids: a multisite PET study approach
Initiative, F. T. A. D. N., Royse, S. K., Minhas, D. S., Lopresti, B. J., Murphy, A., Ward, T., Koeppe, R. A., Bullich, S., DeSanti, S., Jagust, W. J., et al. (2021) · Alzheimer's Research & Therapy · doi:10.1186/s13195-021-00836-1 · Cited by 237 · cited 1×
“34,37 The patient groups were further dichotomized by A β using a previously established SUVR cut-off at 1.11 to test the differences between controls and A β -positive patients grouped by MCI and AD.”
Influential
Research works printed but not linked: 46
- 10.1016/j.jalz.2011.03.003 · DOI · Paper page
- Kantarci K, 2008, Alzheimer Disease: postmortem neuropathologic correlates of antemortem 1H MR spectroscopy metabolite measurements, Riadology, 248, 210
- 10.1523/JNEUROSCI.2027-14.2014 · DOI · Paper page
- 10.1002/ana.25202 · DOI
- 10.1212/WNL.0000000000002672 · DOI
- 10.1212/WNL.0000000000006852 · DOI
- 10.1093/brain/awq208 · DOI
- 10.1212/WNL.0b013e31829a3329 · DOI · Paper page
- 10.1212/WNL.55.2.210 · DOI · Paper page
- 10.1212/WNL.58.6.928 · DOI · Paper page
- 10.1016/j.neurobiolaging.2016.08.022 · DOI
- 10.1016/j.neurobiolaging.2017.12.004 · DOI
- LiangZP.Spatiotemporal imaging with partially separable functions. In:2007 4th IEEE International Symposium on Biomedical Imaging: From Nano to Macro:IEEE.2007. p.988‐991. · DOI · Paper page
- 10.1002/mrm.25168 · DOI
- 10.1002/mrm.26019 · doi:10.1002/mrm.26019
- 10.1109/TBME.2017.2741922 · doi:10.1109/tbme.2017.2741922
- 10.1002/mrm.26972 · DOI
- 10.1002/mrm.27865 · DOI
- 10.1093/brain/awaa264 · DOI
- 10.1016/j.jalz.2011.03.005 · DOI · Paper page
- 10.1016/j.jalz.2011.03.008 · DOI · Paper page
- 10.2967/jnumed.115.166967 · DOI
- 10.1002/mrm.25635 · doi:10.1002/mrm.25635
- 10.1002/mrm.27980 · doi:10.1002/mrm.27980
- 10.1002/mrm.30200 · DOI
- Zhao Y, 2024, Ultrafast Magnetic Resonance Spectroscopic Imaging: Technical Development and Applications
- 10.1109/TBME.2012.2223466 · doi:10.1109/tbme.2012.2223466
- 10.1016/j.neuroimage.2006.01.021 · DOI · Paper page
- 10.2967/jnumed.110.076315 · DOI · Paper page
- 10.1007/s00259-014-2753-3 · DOI · Paper page
- Avants BB, 2009, Advanced normalization tools (ANTS), Insight J, 2, 1
- 10.2967/jnumed.114.148981 · DOI · Paper page
- 10.1126/sciadv.add2870 · DOI
- 10.1016/j.neuroimage.2020.116745 · DOI · Paper page
- MakalicE SchmidtDF.High‐dimensional Bayesian regularised regression with the BayesReg package.arXiv preprint arXiv:161106649.2016.
- Watanabe S., 2013, A widely applicable Bayesian information criterion, J Mach Learn Res, 14, 867
- 10.1212/WNL.0000000000002576 · DOI · Paper page
- 10.1007/s00259-013-2656-8 · DOI
- 10.1212/WNL.0b013e31822dc7e1 · DOI · Paper page
- 10.1016/j.neurobiolaging.2006.06.018 · DOI · Paper page
- 10.1016/S0140-6736(00)02246-7 · DOI · Paper page
- 10.1007/s00330-016-4669-8 · DOI
- 10.1097/00001756-200201210-00041 · DOI · Paper page
- Kantarci K, 2003, Proton MR spectroscopy in mild cognitive impairment and Alzheimer disease: comparison of 1.5 and 3 T, AJNR Am J Neuroradiol, 24, 843
- 10.1016/j.neurobiolaging.2014.07.030 · DOI · Paper page
- 10.1212/WNL.0000000000004421 · DOI
Cited by
Shi, Y., Zhang, R., Li, M., Xia, Y., Zhou, M., Cao, R., Zhou, Q., & Zhang, Y. (2026) · Theranostics · doi:10.7150/thno.131311
“Spatial resolution is limited to ~3-5 mm, which is insufficient for detailed anatomical localization [13,14].”
Self-citation
Metadata
- Authors
- Zhang, M., Hu, J., Zhang, Y., Meng, Z., Zhao, Y., Li, Y., Jin, W., Qian, X., Wang, L., Ye, G., Jiang, X., Li, Y., Ye, J., Tang, H., Liu, J., Nachev, P., Liang, Z., Li, B., & Li, Y.
- Affiliations
- Department of Nuclear Medicine Ruijin Hospital, School of Biomedical Engineering Shanghai Jiao Tong University Shanghai China
- Beckman Institute for Advanced Science and Technology, University of Illinois at Urbana‐Champaign Urbana Illinois USA
- Department of Geriatrics Ruijin Hospital Shanghai Jiao Tong University School of Medicine Shanghai China
- Department of Neurovascular Center Changhai Hospital Naval Medical University Shanghai China
- Department of Neurology and Institute of Neurology Ruijin Hospital Shanghai Jiao Tong University School of Medicine Shanghai China
- Department of Gastroenterology, Songjiang Hospital and Songjiang Research Institute Shanghai Key Laboratory of Emotions and Affective Disorders, State Key Laboratory of Eye Health, Shanghai Jiao Tong University School of Medicine Shanghai China
- High‐Dimensional Neurology Group, Institute of Neurology, University College London London UK
- ORCID
- Li, Yao
- Venue
- Alzheimer's & Dementia
- Publisher
- Wiley
- Published
- 2025-06
- Volume
- 21
- Issue
- 6
- ISSN
- 1552-5260
- 1552-5279
- Cited by
- 2
- References
- 8
- Language
- en
- Funders
- National Natural Science Foundation of China (82372073, 82151314)
- Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning
- Science and Technology Commission of Shanghai Municipality (21ZR1481500)
- Shanghai Municipal Health Commission (202240031)
- Wellcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.